Protective Effect of Aspirin on COVID-19 Patients
NCT04365309
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
128
Enrollment
OTHER
Sponsor class
Conditions
Novel Coronavirus Pneumonia
Aspirin
Treatment
Interventions
DRUG:
Aspirin 100mg
Sponsor
Xijing Hospital